Gizem Levent

Dr. Gizem Levent

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
GLGizem Levent
Gizem Levent
ASAshlynn Schlochtermeier
Ashlynn Schlochtermeier
SISamuel E. Ives
Samuel E. Ives
KNKeri N. Norman
Keri N. Norman
SLSara D. Lawhon
Sara D. Lawhon
HSHarvey Morgan Scott
Harvey Morgan Scott
Salmonella is a leading bacterial foodborne pathogen, causing a significant number of human infections and deaths every year in the United States. Macrolides and 3rd-generation cephalosporins play critical roles in the treatment of human salmonellosis. Use of these antibiotics in beef cattle can select for resistant bacteria that may enter the food chain or spread from the farm via manure. There is a lack of longitudinal research concerning the long-term effects of metaphylactic antibiotic administration. Here, we assessed Salmonella population dynamics during the feeding period until slaughter following single-dose antibiotic treatment. We found no long-term effects of antibiotic use early in the cattle-feeding period on Salmonella prevalence and antimicrobial resistance at slaughter. We identified the pens in which cattle were housed as the factor that contributed most to Salmonella serotypes being shared; importantly, the dominant strain in each pen changed repeatedly over the entire feeding period.

11 July 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
BABabafela Awosile
Babafela Awosile
JFJason Fritzler
Jason Fritzler
GLGizem Levent
Gizem Levent
Md. Kaisar RahmanMd. Kaisar Rahman
Md. Kaisar Rahman
SASamuel Ajulo
Samuel Ajulo
Sumon SarkarSumon Sarkar
Sumon Sarkar
This study was carried out to determine the antimicrobial resistance (AMR) genes and mobile genetic elements of 16 Escherichia coli isolates—with reduced susceptibility to ceftazidime and imipenem—that were recovered from the fecal samples of coyotes and wild hogs from West Texas, USA. Whole-genome sequencing data analyses revealed distinct isolates with a unique sequence type and serotype designation. Among 16 isolates, 4 isolates were multidrug resistant, and 5 isolates harbored at least 1 beta-lactamase gene (blaCMY-2, blaCTX-M-55, or blaCTX-M-27) that confers resistance to beta-lactam antimicrobials. Several isolates carried genes conferring resistance to tetracyclines (tet(A), tet(B), and tet(C)), aminoglycosides (aac(3)-IId, ant(3″)-Ia, aph(3′)-Ia, aph(3″)-lb, aadA5, and aph(6)-ld), sulfonamides (sul1, sul2, and sul3), amphenicol (floR), trimethoprim (dfrA1 and dfrA17), and macrolide, lincosamide, and streptogramin B (MLSB) agents (Inu(F), erm(B), and mph(A)). Nine isolates showed chromosomal mutations in the promoter region G of ampC beta-lactamase gene, while three isolates showed mutations in gyrA, parC, and parE quinolone resistance-determining regions, which confer resistance to quinolones. We also detected seven incompatibility plasmid groups, with incF being the most common. Different types of virulence genes were detected, including those that enhance bacterial fitness and pathogenicity. One blaCMY-2 positive isolate (O8:H28) from a wild hog was also a Shiga toxin-producing E. coli and was a carrier of the stx2A virulence toxin subtype. We report the detection of blaCMY-2, blaCTX-M-55, and blaCTX-M-27 beta-lactamase genes in E. coli from coyotes for the first time. This study demonstrates the importance of wildlife as reservoirs of important multi-drug-resistant bacteria and provides information for future comparative genomic analysis with the limited literature on antimicrobial resistance dynamics in wildlife such as coyotes.
1

16 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OOOlanrewaju J. Ogunrinu
Olanrewaju J. Ogunrinu
KNKeri N. Norman
Keri N. Norman
JVJavier Vinasco
Javier Vinasco
GLGizem Levent
Gizem Levent
SLSara D. Lawhon
Sara D. Lawhon
HSHarvey Morgan Scott
Harvey Morgan Scott
Though carbapenems are not licensed for use in food animals in the U.S., carbapenem resistance among Enterobacteriaceae has been identified in farm animals and their environments. The objective of our study was to determine the extent to which older-generation β-lactam antibiotics approved for use in food animals in the U.S. might differentially select for resistance to antibiotics of critical importance to human health, such as carbapenems.Escherichia coli (E.coli)strains from humans, food animals, or the environment bearing a single β-lactamase gene (n = 20 each) forblaTEM-1,blaCMY-2, andblaCTX-M-*or elseblaKPC/IMP/NDM(due to limited availability, often in combination with otherblagenes), were identified, along with 20E.colistrains lacking any known beta-lactamase genes. Baseline estimates of intrinsic bacterial fitness were derived from the population growth curves. Effects of ampicillin (32 μg/mL), ceftriaxone (4 μg/mL) and meropenem (4 μg/mL) on each strain and resistance-group also were assessed. Further,in vitrobatch cultures were prepared by mixing equal concentrations of 10 representativeE.colistrains (two from each resistance gene group), and each mixture was incubated at 37°C for 24 hours in non-antibiotic cation-adjusted Mueller-Hinton II (CAMH-2) broth, ampicillin + CAMH-2 broth (at 2, 4, 8, 16, and 32 μg/mL) and ceftiofur + CAMH-2 broth (at 0.5, 1, 2, 4, and 8μg/mL). Relative and absolute abundance of resistance-groups were estimated phenotypically. Line plots of the raw data were generated, and non-linear Gompertz models and multilevel mixed-effect linear regression models were fitted to the data. The observed strain growth rate distributions were significantly different across the groups. AmpC strains (i.e.,blaCMY-2) had distinctly less robust (p < 0.05) growth in ceftriaxone (4 μg/mL) compared to extended-spectrum beta-lactamase (ESBL) producers harboringblaCTX-M-*variants. With increasing beta-lactam antibiotic concentrations, relative proportions of ESBLs and CREs were over-represented in the mixed bacterial communities; importantly, this was more pronounced with ceftiofur than with ampicillin. These results indicate that aminopenicillins and extended-spectrum cephalosporins would be expected to propagate carbapenemase-producing Enterobacteriaceae in food animals if and when Enterobacteriaceae from human health care settings enter the food animal environment.

26 May 2021 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
GLGizem Levent
Gizem Levent
ASAshlynn Schlochtermeier
Ashlynn Schlochtermeier
SISamuel E. Ives
Samuel E. Ives
KNKeri N. Norman
Keri N. Norman
SLSara D. Lawhon
Sara D. Lawhon
HSHarvey Morgan Scott
Harvey Morgan Scott
Salmonella serotypes isolated from outbreaks in humans can also be found in beef cattle and feedlots. Virulence factors and antibiotic resistance are among the primary defense mechanisms of Salmonella , and are often associated with clonal expansion.

31 May 2022 in Journal of Food Safety
Verified
Journal Article
Closed access
GCGizem Cufaoglu
Gizem Cufaoglu
GCGorkem Cengiz
Gorkem Cengiz
BABahar Onaran Acar
Bahar Onaran Acar
BYBusra Yesilkaya
Busra Yesilkaya
NANaim Deniz Ayaz
Naim Deniz Ayaz
MGMuammer Goncuoglu
Muammer Goncuoglu

16 April 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
GLGizem Levent
Gizem Levent
RARobin Anderson
Robin Anderson
BPBranko Petrujkic
Branko Petrujkic
TPToni Poole
Toni Poole
HHHaiqi He
Haiqi He
DNDavid J. Nisbet
David J. Nisbet
The gut of food-producing animals is a reservoir for foodborne pathogens. Thymol is bactericidal against foodborne pathogens but rapid absorption of thymol from the proximal gut precludes the delivery of effective concentrations to the lower gut where pathogens mainly colonize. Thymol-β-d-glucopyranoside is reported to be more resistant to absorption than thymol in everted jejunal segments and could potentially function as a prebiotic by resisting degradation and absorption in the proximal gut but being hydrolysable by microbial β-glycosidase in the distal gut. Previous in vitro studies showed bactericidal effects of thymol-β-d-glucopyranoside against Campylobacter, Escherichia coli, and Salmonella enterica serovar Typhimurium in the presence but not absence of intestinal microbes expressing β-glycosidase activity, indicating that hydrolysis was required to obtain antimicrobial activity. Presently, the oral administration of thymol-β-d-glucopyranoside was studied to examine the effects on intestinal carriage of Campylobacter, E. coli, and S. Typhimurium in swine. The effects of thymol-β-d-glucopyranoside or thymol on antimicrobial sensitivity of representative E. coli isolates and characterized Salmonella strains were also explored. Results from two in vivo studies revealed little antimicrobial effects of thymol-β-d-glucopyranoside on Campylobacter, E. coli, or S. Typhimurium in swine gut. These findings add credence to current thinking that hydrolysis and absorption of thymol-β-d-glucopyranoside and thymol may be sufficiently rapid within the proximal gut to preclude delivery to the distal gut. Antibiotic susceptibilities of selected bacterial isolates and strains were mainly unaffected by thymol. Further research is warranted to overcome obstacles, preventing the delivery of efficacious amounts of thymol-β-d-glucopyranoside to the lower gut.